Abstract
Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritis.
Sudha Visvanathan, Joseph C Marini, Josef S Smolen, E William St Clair, Charles Pritchard, William Shergy, Charles Pendley, Daniel Baker, Mohan Bala, Timothy Gathany, John Han and Carrie Wagner
The Journal of Rheumatology July 2007, 34 (7) 1465-1474;
Sudha Visvanathan
Joseph C Marini
Josef S Smolen
E William St Clair
Charles Pritchard
William Shergy
Charles Pendley
Daniel Baker
Mohan Bala
Timothy Gathany
John Han
In this issue
The Journal of Rheumatology
Vol. 34, Issue 7
1 Jul 2007
Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritis.
Sudha Visvanathan, Joseph C Marini, Josef S Smolen, E William St Clair, Charles Pritchard, William Shergy, Charles Pendley, Daniel Baker, Mohan Bala, Timothy Gathany, John Han, Carrie Wagner
The Journal of Rheumatology Jul 2007, 34 (7) 1465-1474;
Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritis.
Sudha Visvanathan, Joseph C Marini, Josef S Smolen, E William St Clair, Charles Pritchard, William Shergy, Charles Pendley, Daniel Baker, Mohan Bala, Timothy Gathany, John Han, Carrie Wagner
The Journal of Rheumatology Jul 2007, 34 (7) 1465-1474;